Radiation therapy for muscle-invasive bladder cancer: Treatment planning and delivery in the 21st century

被引:19
作者
McBain, CA [1 ]
Logue, JP [1 ]
机构
[1] Christie Hosp, NHS Trust, Acad Dept Radiat Oncol, Manchester M20 4BX, Lancs, England
关键词
D O I
10.1016/j.semradonc.2004.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advances in radiation treatment planning, verification, and delivery provide a means to optimize radiation treatment for bladder cancer and overcome difficulties which have previously limited the success of this treatment. They offer the opportunity to enhance the therapeutic ratio by reducing the volume of normal tissue irradiated and by increasing radiation dose or using more intensive fractionation and synchronous chemotherapy regimes. In this review, we aim to present a practical overview of radiation protocols for bladder cancer, covering issues relating to patient selection, choice of target volumes, verification, dose, and fractionation. Alternative methods of improving treatment accuracy such as image-guided radiotherapy and intensity modulated radiotherapy are also discussed. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 62 条
[1]   Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer [J].
Agerbaek, M ;
Alsner, J ;
Marcussen, N ;
Lundbeck, F ;
von der Maase, H .
BRITISH JOURNAL OF CANCER, 2003, 89 (02) :298-304
[2]  
[Anonymous], 1993, 50 ICRU
[3]   Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique [J].
Borgaonkar, S ;
Jain, A ;
Bollina, P ;
McLaren, DB ;
Tulloch, D ;
Kerr, GR ;
Howard, GCW .
CLINICAL ONCOLOGY, 2002, 14 (02) :141-147
[4]   Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer [J].
Buchali, A ;
Koswig, S ;
Dinges, S ;
Rosenthal, P ;
Salk, J ;
Lackner, G ;
Böhmer, D ;
Schlenger, L ;
Budach, V .
RADIOTHERAPY AND ONCOLOGY, 1999, 52 (01) :29-34
[5]  
CHAKRAVARTI A, 2002, P AN M AM SOC CLIN, V21, pA179
[6]  
CHUNG P, 2003, INT J RADIAT ONCOL, V57, pS178
[7]   A PILOT-STUDY OF ACCELERATED FRACTIONATION IN THE RADIOTHERAPY OF INVASIVE-CARCINOMA OF THE BLADDER [J].
COLE, DJ ;
DURRANT, KR ;
ROBERTS, JT ;
DAWES, PJTK ;
YOSEF, H ;
HOPEWELL, JW .
BRITISH JOURNAL OF RADIOLOGY, 1992, 65 (777) :792-798
[8]   Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation [J].
Coppin, CML ;
Gospodarowicz, MK ;
James, K ;
Tannock, IF ;
Zee, B ;
Carson, J ;
Pater, J ;
Sullivan, LD .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2901-2907
[9]   Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy [J].
Cowan, RA ;
McBain, CA ;
Ryder, WDJ ;
Wylie, JP ;
Logue, JP ;
Turner, SL ;
Van Der Voet, J ;
Collins, CD ;
Khoo, VS ;
Read, GR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :197-207
[10]   CLINICAL IMPRESSIONS IN 100 CONSECUTIVE CASES OF CARCINOMA OF THE URINARY BLADDER TREATED BY SUPERVOLTAGE [J].
CUCCIA, CA ;
JONES, S ;
CRIGLER, CM .
JOURNAL OF UROLOGY, 1958, 79 (01) :99-109